These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8356961)

  • 41. Measles mortality and vaccine efficacy in rural West Africa.
    Hull HF; Williams PJ; Oldfield F
    Lancet; 1983 Apr; 1(8331):972-5. PubMed ID: 6132278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alternative routes of measles immunization: a review.
    Cutts FT; Clements CJ; Bennett JV
    Biologicals; 1997 Sep; 25(3):323-38. PubMed ID: 9325001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Invited commentary: vaccine failure or failure to vaccinate?
    Strebel P; Guris D; Papania M; Cochi S
    Am J Epidemiol; 1999 Feb; 149(4):302-3. PubMed ID: 10025470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren.
    Bennett JV; Fernandez de Castro J; Valdespino-Gomez JL; Garcia-Garcia Mde L; Islas-Romero R; Echaniz-Aviles G; Jimenez-Corona A; Sepulveda-Amor J
    Bull World Health Organ; 2002; 80(10):806-12. PubMed ID: 12471401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysis.
    Low N; Kraemer S; Schneider M; Restrepo AM
    Vaccine; 2008 Jan; 26(3):383-98. PubMed ID: 18082295
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sex-specific differences in mortality after high-titre measles immunization in rural Senegal.
    Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Markowitz L; Rhodes P; Whittle H
    Bull World Health Organ; 1994; 72(5):761-70. PubMed ID: 7955026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of cross-sex transmission on measles mortality in rural Senegal.
    Aaby P
    Lancet; 1992 Aug; 340(8816):388-91. PubMed ID: 1353555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of Edmonston-Zagreb and Schwarz strains of measles vaccine given by aerosol or subcutaneous injection.
    Khanum S; Uddin N; Garelick H; Mann G; Tomkins A
    Lancet; 1987 Jan; 1(8525):150-3. PubMed ID: 2879981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trial of Edmonston-Zagreb measles vaccine in infants aged under nine months.
    Pongrithsukda V; Gluck R; Suwatanapongched S; Kaewmalung P; Muyakul J
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):347-50. PubMed ID: 1818384
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized Trials Comparing Inactivated Vaccine After Medium- or High-titer Measles Vaccine With Standard Titer Measles Vaccine After Inactivated Vaccine: A Meta-analysis.
    Aaby P; Ravn H; Benn CS; Rodrigues A; Samb B; Ibrahim SA; Libman MD; Whittle HC
    Pediatr Infect Dis J; 2016 Nov; 35(11):1232-1241. PubMed ID: 27753769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immuno-epidemiologic considerations on the prevention of measles in Mexico].
    Díaz-Ortega JL; Valdespino-Gómez JL; Zárate-Aquino ML; Camacho-Amor ML; González-Velázquez MS; Chávez-San Juan R
    Bol Med Hosp Infant Mex; 1990 Jul; 47(7):474-81. PubMed ID: 2206412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunization of young infants with Edmonston-Zagreb measles vaccine.
    Markowitz LE; Bernier RH
    Pediatr Infect Dis J; 1987 Sep; 6(9):809-12. PubMed ID: 3313247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Head-to-head immunogenicity comparison of Edmonston-Zagreb vs. AIK-C measles vaccine strains in infants aged 8-12 months: A randomized clinical trial.
    Izadi S; Zahraei SM; Salehi M; Mohammadi M; Tabatabaei SM; Mokhtari-Azad T
    Vaccine; 2018 Jan; 36(5):631-636. PubMed ID: 29289382
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measles virus antibody responses in children randomly assigned to receive standard-titer edmonston-zagreb measles vaccine at 4.5 and 9 months of age, 9 months of age, or 9 and 18 months of age.
    Martins C; Garly ML; Bale C; Rodrigues A; Njie-Jobe J; Benn CS; Whittle H; Aaby P
    J Infect Dis; 2014 Sep; 210(5):693-700. PubMed ID: 24688075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low seroconversion rates to measles vaccine among children in Nigeria.
    Adu FD; Akinwolere OA; Tomori O; Uche LN
    Bull World Health Organ; 1992; 70(4):457-60. PubMed ID: 1394778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The control of viral diseases in the developing countries with the use of existing vaccines].
    Gendon IuZ
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Sep; (9):77-82. PubMed ID: 1759532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination of attenuated measles vaccine (Schwarz) with meningococcus A and A + C vaccine.
    Ajjan N; Fayet MT; Biron G; Charbonnier C; Nicolas A; Triau R; Roumiantzeff M
    Dev Biol Stand; 1978; 41():209-16. PubMed ID: 111980
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunization of 6 and 9 month old infants with AIK-C, Edmonston-Zagreb, Leningrad-16 and Schwarz strains of measles vaccine.
    Bolotovski VM; Grabowsky M; Clements CJ; Albrecht P; Brenner ER; Zargaryantzs AI; Litvinov SK; Mikheyeva IV
    Int J Epidemiol; 1994 Oct; 23(5):1069-77. PubMed ID: 7860158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Measles vaccines used in Japan.
    Hirayama M
    Rev Infect Dis; 1983; 5(3):495-503. PubMed ID: 6879005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.